TVA Medical, Inc. today announced several clinical updates involving its everlinQ™ endoAVF System, an innovative endovascular technique to create hemodialysis access without open surgery, with other potential clinical applications. The everlinQ endoAVF System has European CE Mark and Health Canada Medical Device License for end-stage renal disease (ESRD) patients who need hemodialysis, and commercialization has begun at select centers in Europe. It is not commercially available in the United States and is currently under review by the U.S. Food and Drug Administration. (read more)
When you peek into the University of Kansas Hospital’s Neonatal Intensive Care Unit, it probably appears to be an ordinary nursery full of tiny preemies. However, thanks to a $73,000 grant from Royal Charities, they are doing something groundbreaking for parents like Sam Last, a soldier deployed in Kuwait.
The hospital has installed what they call an “Angel Eye” into the each baby’s incubator. This way, parents who are separated from their child can check in on them whenever they like. For Sam, who is 7,000 miles away from his newborn baby girl Charlie, it means the world. (read more)
Encore Healthcare, LLC, announced the purchase of Nexus, a HIPAA-compliant care management platform from Nashville-based Jumpstart Foundry alumnus, Evermind, Inc., accelerating its leadership, expertise and innovation in post-acute respiratory population health management. (read more)
Ryan Macy had a vision for a workflow technology harnessing the power of wearable technology – specifically, Google Glass – that would improve health care.
There were just a few obstacles.
First, when it comes to Google Glass and similar wearables, “the platform is not at a place yet to be something you can build on top of,” Macy said. And once the startup decided to focus on the post-acute care market, it became clear wearables were too advanced a tool to introduce. In skilled-nursing facilities and similar settings, Macy said, “they barely have computers.” (read more)
GenomOncology today announced the appointment of Joshua F. Coleman, M.D., as Vice President of Medical Affairs.
Dr. Coleman will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic sequencing data and clinical decision support, from quality control through reporting. (read more)
PatientPoint® has announced the purchase of MedCenterDisplay, a Nashville-based provider of digital signage, mobile apps and digital marketing solutions for hospitals. This latest acquisition solidifies the leadership position PatientPoint holds within the hospital sector and expands its suite of solutions to help hospitals communicate with and educate patients and, ultimately, enhance the patient experience. (read more)
Fluidigm Corporation (FLDM) and GenomOncology today announced a distribution agreement to co-market the GO Clinical Workbench™ for molecular interpretation of somatic variants identified using Fluidigm systems. An elegant solution for clinical research laboratories seeking accuracy, flexibility, and scalability, this combined offering will enable laboratories to achieve greater workflow efficiencies and productivity from NGS library preparation, variant annotation and reporting. (Read more)
Local company Kem Krest is pitching in to help parents of babies in intensive care.
The Elkhart company donated money for specialized cameras in Memorial Hospital’s NICU.
These cameras are a big deal to families. Parents and nurses faces light up when they talk about the Angel Eye system that’s now up-and-running. (Read More)
BioStable Science & Engineering, Inc. announced today that it has completed a direct de novo application to the U.S. Food and Drug Administration (FDA) for Class II designation of the HAART 300 Aortic Annuloplasty Device. Submission of the de novo request is an important milestone in BioStable’s efforts to bring the potential benefits of valve repair to U.S. patients suffering with aortic valve insufficiency. (read more)